Literature DB >> 21018724

The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research.

H C NAUTS, W E SWIFT, B L COLEY.   

Abstract

Entities:  

Keywords:  BIOGRAPHY; CANCER/therapy; HISTORY; TOXIN AND ANTITOXIN

Mesh：

Substances：

Year:  1946        PMID： 21018724

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  72 in total

Review 1.  Microorganisms and cancer: quest for a therapy.

Authors:  A M Chakrabarty
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

Review 2.  Endogenous synthesis of peptidoglycan in eukaryotic cells; a novel concept involving its essential role in cell division, tumor formation and the biological clock.

Authors:  C A Roten; D Karamata
Journal:  Experientia       Date:  1992-10-15

3.  [Immunotherapy of head and neck tumors: Highlights of the ASCO Meeting 2015].

Authors:  S Laban; J Doescher; P J Schuler; L Bullinger; C Brunner; J A Veit; T K Hoffmann
Journal:  HNO       Date:  2015-09       Impact factor: 1.284

Review 4.  Tumour-targeting bacteria engineered to fight cancer.

Authors:  Shibin Zhou; Claudia Gravekamp; David Bermudes; Ke Liu
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

Review 5.  Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer.

Authors:  Matteo Bellone; Arianna Brevi; Samuel Huber
Journal:  Microbiol Mol Biol Rev       Date:  2020-03-04       Impact factor: 11.056

6.  Amazing IL-9: revealing a new function for an "old" cytokine.

Authors:  Edgar Schmitt; Tobias Bopp
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

7.  Role of respiratory-burst products from polymorphonuclear leukocytes in the antitumor activity of Propionibacterium acnes vaccine.

Authors:  E A Murano; C S Cummins
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

8.  Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma.

Authors:  Travis B Kidner; Donald L Morton; Delphine J Lee; Mary Hoban; Leland J Foshag; Roderick R Turner; Mark B Faries
Journal:  J Immunother       Date:  2012 Nov-Dec       Impact factor: 4.456

Review 9.  An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications.

Authors:  Seung Min Bang; June Won Cheong; Woo Ick Yang; Jee Sook Hahn
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

10.  Bacteria under SOS evolve anticancer phenotypes.

Authors:  Shatha F Dallo; Tao Weitao
Journal:  Infect Agent Cancer       Date:  2010-02-05       Impact factor: 2.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.